Direct, indirect and intangible costs incurred by leptospirosis patients: the magnitude, aspects and methods of assessing the costs - a systematic review and meta-analysis protocol.
- DOI
- 10.1136/bmjopen-2025-106730
- Published
- 2026 Jan 27
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2025-106730,
title = {Direct, indirect and intangible costs incurred by leptospirosis patients: the magnitude, aspects and methods of assessing the costs - a systematic review and meta-analysis protocol.},
author = {Jayasinghe MS and Warnasekara J and Gunarathna SP and Wickramasinghe ND and Agampodi S},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2025-106730},
url = {https://doi.org/10.1136/bmjopen-2025-106730}
}RIS
TY - JOUR TI - Direct, indirect and intangible costs incurred by leptospirosis patients: the magnitude, aspects and methods of assessing the costs - a systematic review and meta-analysis protocol. AU - Jayasinghe MS AU - Warnasekara J AU - Gunarathna SP AU - Wickramasinghe ND AU - Agampodi S PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2025-106730 UR - https://doi.org/10.1136/bmjopen-2025-106730 ER -
APA
MS, J., J, W., SP, G., ND, W., & S, A. (2026). Direct, indirect and intangible costs incurred by leptospirosis patients: the magnitude, aspects and methods of assessing the costs - a systematic review and meta-analysis protocol.. BMJ open. https://doi.org/10.1136/bmjopen-2025-106730
Source records
- pubmed · retrieved 2026-09-26T04:22:43.749Z